Patents by Inventor Thomas J. Fahey, III

Thomas J. Fahey, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10889865
    Abstract: The invention relates to methods and kits for detecting thyroid cancer by detecting differences in the expression of genes that are differentially expressed in thyroid cancer cells.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: January 12, 2021
    Assignee: Cornell University
    Inventors: Thomas J. Fahey, III, Nimmi Kapoor, Theresa Scognamiglio
  • Publication number: 20170166980
    Abstract: The invention relates to methods and kits for detecting thyroid cancer by detecting differences in the expression of genes that are differentially expressed in thyroid cancer cells.
    Type: Application
    Filed: February 23, 2017
    Publication date: June 15, 2017
    Inventors: Thomas J. Fahey, III, Nimmi Kapoor, Theresa Scognamiglio
  • Patent number: 9587279
    Abstract: The invention relates to methods and kits for detecting thyroid cancer by detecting differences in the expression of genes that are differentially expressed in thyroid cancer cells.
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: March 7, 2017
    Assignee: Cornell University
    Inventors: Thomas J. Fahey, III, Nimmi Kapoor, Theresa Scognamiglio
  • Patent number: 9175352
    Abstract: The application describes methods for accurately evaluating whether thyroid test samples, especially indeterminate thyroid samples, are benign or malignant.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: November 3, 2015
    Assignee: Cornell University
    Inventors: Xavier M. Keutgen, Thomas J. Fahey, III, Olivier Elemento, Rasa Zarnegar
  • Publication number: 20150167094
    Abstract: The invention relates to methods and kits for detecting thyroid cancer by detecting differences in the expression of genes that are differentially expressed in thyroid cancer cells.
    Type: Application
    Filed: November 22, 2013
    Publication date: June 18, 2015
    Applicant: Cornell University
    Inventors: Thomas J. Fahey, III, Nimmi Kapoor, Theresa Scognamiglio
  • Publication number: 20150125387
    Abstract: The application describes methods for accurately evaluating whether thyroid test samples, especially indeterminate thyroid samples, are benign or malignant.
    Type: Application
    Filed: December 30, 2014
    Publication date: May 7, 2015
    Inventors: Xavier M. Keutgen, Thomas J. Fahey, III, Olivier Elemento, Rasa Zarnegar
  • Patent number: 8945829
    Abstract: The application describes methods for accurately evaluating whether thyroid test samples, especially indeterminate thyroid samples, are benign or malignant.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: February 3, 2015
    Assignee: Cornell University
    Inventors: Xavier M. Keutgen, Thomas J. Fahey, III, Olivier Elemento, Rasa Zarnegar
  • Publication number: 20140099261
    Abstract: The application describes methods for accurately evaluating whether thyroid test samples, especially indeterminate thyroid samples, are benign or malignant.
    Type: Application
    Filed: September 20, 2013
    Publication date: April 10, 2014
    Applicant: Cornell University
    Inventors: Xavier M. Keutgen, Thomas J. Fahey, III, Olivier Elemento, Rasa Zarnegar
  • Publication number: 20110251091
    Abstract: The invention relates to methods and kits for detecting thyroid cancer by detecting differences in the expression of genes that are differentially expressed in thyroid cancer cells.
    Type: Application
    Filed: September 11, 2009
    Publication date: October 13, 2011
    Applicant: Cornell University
    Inventors: Thomas J. Fahey, III, Nimmi Arora, Theresa Seognamiglio, Raymond K. Blanchard, Guozhen Liu
  • Patent number: 5145676
    Abstract: The present invention relates to the treatment of wound healing dysfunction by the administration of one or more would healing modulators. The wound healing modulator may be selected from appropriate wound healing agents and binding partners, and particularly agents that enhance wound healing. The agent may comprise a cytokine, or mixture of cytokines that are also capable of binding to heparin, and inducing localized inflammation characterized by polymorphonuclear cell infiltration when administered subcutaneously. Particular agents comprise the inflammatory cytokines MIP-1, MIP-1.alpha., MIP-1.beta. and MIP-2. Diagnostic and therapeutic utilities are proposed, and pharmaceutical compositions are likewise set forth.
    Type: Grant
    Filed: February 7, 1991
    Date of Patent: September 8, 1992
    Assignee: The Rockefeller University
    Inventors: Thomas J. Fahey, III, Barbara A. Sherry, Anthony Cerami